BLLN · Insider Trading
BillionToOne, Inc. Class A Common Stock
Every open-market purchase and sale reported by BLLN officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-19 | Thomas P. Lynch | See Remarks | M | +2,000 | +$17.30K |
| 2026-10-16 | Oguzhan Atay | Chairman and CEO | MIXED | −2,667 | −$1.07M |
| 2026-10-14 | Oguzhan Atay | Chairman and CEO | MIXED | −2,667 | −$1.78M |
| 2026-10-13 | Thomas P. Lynch | See Remarks | M | +8,000 | +$69.20K |
| 2026-10-07 | John Roderick ten Bosch | SVP of Laboratory Operations | Sell | −2,834 | −$298.00K |
| 2026-10-07 | David Tsao | Chief Technology Officer | MIXED | — | −$2.11M |
| 2026-09-30 | Oguzhan Atay | Chairman and CEO | MIXED | −2,666 | −$1.30M |
| 2026-09-28 | John Roderick ten Bosch | SVP of Laboratory Operations | Sell | −1,416 | −$169.92K |
| 2026-09-28 | David Tsao | Chief Technology Officer | MIXED | — | −$407.29K |
| 2026-09-23 | John Roderick ten Bosch | SVP of Laboratory Operations | Sell | −1,416 | −$150.96K |
| 2026-09-21 | Thomas P. Lynch | See Remarks | MIXED | — | −$3.40M |
| 2026-09-16 | Oguzhan Atay | Chairman and CEO | MIXED | −5,332 | −$2.96M |
| 2026-09-14 | Shan Riku Sakakibara | Chief Product Officer | G | −3,500 | — |
| 2026-09-11 | John Roderick ten Bosch | SVP of Laboratory Operations | Sell | −1,416 | −$138.12K |
| 2026-09-11 | David Tsao | Chief Technology Officer | MIXED | — | −$1.92M |
| 2026-09-10 | Oguzhan Atay | Chairman and CEO | MIXED | — | — |
| 2026-09-10 | Thomas P. Lynch | See Remarks | MIXED | — | −$1.73M |
| 2026-09-08 | David Tsao | Chief Technology Officer | MIXED | — | — |
| 2026-08-28 | Krishna Kittu Kolluri | Director | J | −406,198 | — |
| 2026-08-27 | John Roderick ten Bosch | SVP of Laboratory Operations | Sell | −1,417 | −$141.70K |
| 2026-08-27 | David Tsao | Chief Technology Officer | MIXED | — | −$972.00K |
| 2026-08-12 | John Roderick ten Bosch | SVP of Laboratory Operations | Sell | −1,417 | −$131.58K |
| 2026-08-12 | David Tsao | Chief Technology Officer | MIXED | — | −$900.60K |
| 2026-08-07 | Oguzhan Atay | Chairman and CEO | MIXED | — | −$2.29M |
| 2026-08-07 | Oguzhan Atay | Chairman and CEO | MIXED | — | −$2.29M |
| 2026-08-05 | Oguzhan Atay | Chairman and CEO | MIXED | −12,500 | −$6.08M |
| 2026-08-04 | Shan Riku Sakakibara | Chief Product Officer | Sell | −4,000 | −$560.84K |
| 2026-07-20 | Nancy JoAnn Johnson | See Remarks | Sell | −14,199 | −$1.82M |
| 2026-07-15 | John Roderick ten Bosch | SVP of Laboratory Operations | Sell | −4,251 | −$533.33K |
| 2026-07-15 | David Tsao | Chief Technology Officer | MIXED | — | −$2.44M |
| 2026-07-13 | Shan Riku Sakakibara | Chief Product Officer | MIXED | −4,000 | −$880.73K |
| 2026-07-13 | Oguzhan Atay | Chairman and CEO | MIXED | — | −$1.54M |
| 2026-07-08 | Oguzhan Atay | Chairman and CEO | MIXED | −12,500 | −$4.66M |
| 2026-07-06 | Nancy JoAnn Johnson | See Remarks | Sell | −801 | −$100.06K |
| 2026-07-01 | John Roderick ten Bosch | SVP of Laboratory Operations | Sell | −1,416 | −$169.92K |
| 2026-06-26 | Shan Riku Sakakibara | Chief Product Officer | MIXED | −4,000 | −$845.40K |
| 2026-06-17 | John Roderick ten Bosch | See Remarks | Sell | −2,832 | −$287.36K |
| 2026-06-17 | David Tsao | Chief Technology Officer | MIXED | — | −$1.99M |
| 2026-06-12 | Akshay Rai | Director | A | +3,017 | — |
| 2026-06-12 | Anthony Pagano | Director | A | +3,017 | — |
| 2026-06-12 | Krishna Kittu Kolluri | Director | A | +3,017 | — |
| 2026-06-12 | Firat Ileri | Director | A | +3,017 | — |
| 2026-06-12 | Thomas S Bremner | Director | A | +3,017 | — |
| 2026-06-11 | NeoTribe Ventures I, L.P. | 10%+ Owner | J | −3,051,657 | — |
| 2026-06-11 | Krishna Kittu Kolluri | Director | J | −419,751 | — |
| 2026-06-10 | Shan Riku Sakakibara | Chief Product Officer | Sell | −8,000 | −$785.80K |
| 2026-06-10 | Nancy JoAnn Johnson | See Remarks | Sell | −14,000 | −$1.40M |
| 2026-06-10 | Oguzhan Atay | See Remarks | MIXED | −12,500 | −$3.72M |
| 2026-05-13 | NeoTribe Partners I, LLC | 10%+ Owner | J | −3,051,657 | — |
| 2026-05-13 | Krishna Kittu Kolluri | Director | J | −419,751 | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| NeoTribe Partners I, LLC | 10%+ Owner | 2,439,258 | $255.32M |
| Shan Riku Sakakibara | Chief Product Officer | 196,500 | $20.57M |
| Oguzhan Atay | Chairman and CEO | 149,268 | $15.62M |
| NeoTribe Ventures I, L.P. | 10%+ Owner | 92,785 | $9.71M |
| Krishna Kittu Kolluri | Director | 69,189 | $7.24M |
| Firat Ileri | Director | 40,331 | $4.22M |
| John Roderick ten Bosch | SVP of Laboratory Operations | 20,802 | $2.18M |
| Collective CommV Hummingbird | 10%+ Owner | 18,845 | $1.97M |
| Akshay Rai | Director | 14,026 | $1.47M |
| Thomas S Bremner | Director | 11,350 | $1.19M |
| Thomas P. Lynch | See Remarks | 10,700 | $1.12M |
| Anthony Pagano | Director | 7,913 | $828.25K |
| Nancy JoAnn Johnson | See Remarks | 7,806 | $817.05K |
| David Tsao | Chief Technology Officer | 2,929 | $306.58K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the BLLN quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.